Product Information
ITRACONAZOLE 100 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.9102 per EA under NDC 16571024503. Its NADAC has been published 53 times since Oct 1, 2025.
FDA first approved this application on Dec 13, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571024503
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ITRACONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205724FDA Approved
12/13/2016
TE Code
AB
On Market Since
2/3/2025
Pharmacological Classes
Price Statistics
The NADAC for ITRACONAZOLE 100 MG CAPSULE has been published 53 times since Oct 1, 2025, and over the history we have for it it has declined 3.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9102 per EA |
|---|---|
| All-time high | $0.9471 (Nov 12, 2025) |
| All-time low | $0.7974 (Jan 21, 2026) |
| 52-week high | $0.9471 |
| 52-week low | $0.7974 |
| Median price | $0.8752 |
| Average price | $0.8640 |
| Largest weekly change | -9.4% (Jan 21, 2026) |
| Weeks tracked | 53 |
| Tracking since | Oct 1, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Itraconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ITRACONAZOLE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ITRACONAZOLE 100 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.9102 per EA (NDC 16571024503), effective Sep 30, 2026.
How has the price of ITRACONAZOLE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ITRACONAZOLE 100 MG CAPSULE has declined 3.5%. It has been tracked across 53 weekly CMS publications since Oct 1, 2025.
What are the highest and lowest recorded NADAC prices for ITRACONAZOLE 100 MG CAPSULE?
Since Oct 1, 2025, the NADAC for ITRACONAZOLE 100 MG CAPSULE has ranged from a low of $0.7974 (Jan 21, 2026) to a high of $0.9471 (Nov 12, 2025), with a median of $0.8752 per EA.
Are there cheaper alternatives to ITRACONAZOLE 100 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ITRACONAZOLE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ITRACONAZOLE 100 MG CAPSULE?
ITRACONAZOLE 100 MG CAPSULE (NDC 16571024503) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.